ISSN: 2155-6105

Zeitschrift für Suchtforschung und -therapie

Offener Zugang

Unsere Gruppe organisiert über 3000 globale Konferenzreihen Jährliche Veranstaltungen in den USA, Europa und anderen Ländern. Asien mit Unterstützung von 1000 weiteren wissenschaftlichen Gesellschaften und veröffentlicht über 700 Open Access Zeitschriften, die über 50.000 bedeutende Persönlichkeiten und renommierte Wissenschaftler als Redaktionsmitglieder enthalten.

Open-Access-Zeitschriften gewinnen mehr Leser und Zitierungen
700 Zeitschriften und 15.000.000 Leser Jede Zeitschrift erhält mehr als 25.000 Leser

Indiziert in
  • CAS-Quellenindex (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Öffnen Sie das J-Tor
  • Genamics JournalSeek
  • Akademische Schlüssel
  • JournalTOCs
  • SafetyLit
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • Elektronische Zeitschriftenbibliothek
  • RefSeek
  • Hamdard-Universität
  • EBSCO AZ
  • OCLC – WorldCat
  • SWB Online-Katalog
  • Virtuelle Bibliothek für Biologie (vifabio)
  • Publons
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • ICMJE
Teile diese Seite

Abstrakt

Change in Neurocognition in People with Co-occurring Alcohol Misuse and Depression: 12-Month Follow-up

Sally Ann Hunt, Amanda Louise Baker, Patricia T. Michie and Frances J. Kay-Lambkin

Objective: Co-occurring alcohol misuse and depression (CAD) are highly prevalent and are both with associated cognitive impairments. Few studies have assessed how cognitive functioning changes over time in association with improvements in alcohol use and/or depression. This is the first study to assess cognitive function and symptoms of depression and alcohol use in a CAD sample at baseline and again at 12-months. We explored whether reduction in alcohol use or improvement in symptoms of depression were associated with changes in cognitive functioning.

Methods: Neuropsychological assessment was administered at baseline and after 12-months in a CAD sample of 71 people who had participated in a psychological intervention in the interim. Changes in alcohol use and depression over 12 months were interpreted as potential factors in improvement in neuropsychological function.

Results: Depressive symptoms and alcohol use improved over 12-months while overall neuropsychological test performance was stable. Improvement in verbal memory, working memory and executive function was predicted by improvement in depressive symptoms measured by the BDI-II, but not by change in alcohol use quantity or frequency of heavy drinking.

Conclusion: Among people with CAD, alleviation of the symptoms of depression may have greater influence on cognitive functioning in areas such as memory and executive function, than a reduction in alcohol use. Further treatment outcome research in CAD samples should include neurocognitive assessments in order to elucidate our understanding of cognitive impairments and potential improvements with intervention.